SCM
Stonepine Capital Management Portfolio holdings
AUM
$123M
1-Year Est. Return
43.21%
1 Year Est. Return
+43.21%
AUM
$102M
AUM Growth
-$1.25M
(-1.2%)
Holding
86
Top Buys
| 1 | +$3.1M | |
| 2 | +$2.84M | |
| 3 | +$2.18M | |
| 4 |
ITOS
iTeos Therapeutics
ITOS
|
+$1.99M |
| 5 |
Nektar Therapeutics
NKTR
|
+$1.3M |
Top Sells
| 1 | +$7.23M | |
| 2 | +$3.69M | |
| 3 | +$3.04M | |
| 4 |
Establishment Labs
ESTA
|
+$2.88M |
| 5 |
Galapagos
GLPG
|
+$2.36M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPTN
76
DELISTED
OptiNose
OPTN
| – | – |
-788,647
|
|
||
|
PROF
77
Profound Medical
PROF
$198M
| – | – |
-139,942
|
|
||
78
PolyPid
PYPD
$57.1M
| – | – |
-54,975
|
|
||
79
RenovoRx
RNXT
$29.5M
| – | – |
-278,188
|
|
||
|
SCPH
80
DELISTED
scPharmaceuticals
SCPH
| – | – |
-347,687
|
|
||
|
SLRN
81
DELISTED
ACELYRIN
SLRN
| – | – |
-167,580
|
|
||
|
THRD
82
DELISTED
Third Harmonic Bio
THRD
| – | – |
-212,783
|
|
||
83
UroGen Pharma
URGN
$1.13B
| – | – |
-333,400
|
|
||
84
Exagen
XGN
$207M
| – | – |
-95,747
|
|
||
|
SEPN
85
Septerna Inc
SEPN
$895M
| – | – |
-68,084
|
|
||
|
WHWK
86
Whitehawk Therapeutics
WHWK
$99.9M
| – | – |
-46,698
|
|